Explore the Federal Circuit's exclusive authority over pharmaceutical patent cases, covering key precedents like Mylan, Hatch-Waxman disputes, and the impact on generic drug timelines.
May, 25 2025
Aug, 25 2026
Oct, 21 2025
Oct, 3 2025
Jan, 28 2026